Fadi Sawaya, Bernard Abi-Saleh, Abbas Hoteit, Jennifer Jdaidany, Mohamad B Moumneh, Bernard Harbieh, Maurice Khoury, Salim Aramouni, Farah Abdulhai, Marwan Refaat
BACKGROUND: Left atrial appendage (LAA) closure is an alternative to chronic anticoagulation for stroke prevention in patients with nonvalvular atrial fibrillation. Multiple devices were used for LAA closure, with the Amplatzer Amulet LAA Occluder (Abbott, Chicago, IL, USA) and Watchman device (Boston Scientific, Marlborough, MA, USA) being the most commonly used in clinical practice. In August 2021, the FDA approved the use of the Amplatzer Amulet LAA Occluder. There is still a knowledge gap in the safety profile of the Amplatzer Amulet LAA Occluder device in comparison to the Watchman device...
March 2024: Curēus